|
Medical University of South Carolina
Charleston, South Carolina Visit https://careers.ons.org/jobs/18481520/registered-nurse-ii-chemotherapy-infusion-4-000-sign-on-bonus to view the full article online. |
|
UVA Medical Center
Charlottesville, Virginia Visit https://careers.ons.org/jobs/18238915/registered-nurse-oncology-infusion-center to view the full article online. |
|
Beverly Hospital
Beverly, Massachusetts Visit https://255033.pool.career-services.naylor.com/jobs/18500833 to view the full article online. |
|
Ochsner Health
New Orleans, Louisiana Visit https://255033.pool.career-services.naylor.com/jobs/18385417 to view the full article online. |
|
University of Utah Health
Salt Lake City, Utah Visit https://255033.pool.career-services.naylor.com/jobs/18428038 to view the full article online. |
|
Advocate Aurora Health
Racine, Wisconsin Visit https://255033.pool.career-services.naylor.com/jobs/18414848 to view the full article online. |
|
Concord Hospital
Concord, New Hampshire Visit https://255033.pool.career-services.naylor.com/jobs/18471560 to view the full article online. |
|
Kaiser Permanente
Los Angeles, California Visit https://255033.pool.career-services.naylor.com/jobs/18481980 to view the full article online. |
|
For nearly 2,500 years, nonmaleficence, or "do no harm," has been a fundamental tenet of medical ethics. Yet none of today’s U.S. breast, cervical, colorectal, lung, or prostate cancer screening guidelines report all of the harms associated with screening tests, researchers said in study results published in Annals of Internal Medicine.
Visit https://voice.ons.org/news-and-views/most-cancer-screening-guidelines-dont-disclose-potential-harms to view the full article online. |
|
Under the U.S. Food and Drug Administration’s (FDA’s) fast-track approval process, nadofaragene firadenovec-vncg (Adstiladrin®) became the first gene therapy approved for the treatment of high-risk non-muscle invasive bladder cancer.
Visit https://voice.ons.org/news-and-views/oncology-drug-reference-sheet-nadofaragene-firadenovec-vncg to view the full article online. |
|
"The bell can have so much more meaning and significance than just the end of treatment. So, work with your patients to define what the significance of that bell can mean," ONS member Monica Cfarku, RN, MSN, BMTCN®, CCM, NE-BC, associate vice president and chief of oncology nursing at Duke Cancer Institute in Durham, NC, and member of the North Carolina Triangle ONS Chapter, told Jaime Weimer, MSN, RN, AGCNS-BC, AOCNS®, oncology clinical specialist at ONS.
Visit https://www.ons.org/podcasts/episode-257-redefining-bell-ethics-hope-oncology-nurses-and-patients to view the full article online. |
